Vaccinia Related Kinase 2 (VRK2) (Middle Region) Peptide
VRK2
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5671955
Aperçu rapide pour Vaccinia Related Kinase 2 (VRK2) (Middle Region) Peptide (ABIN5671955)
Antigène
VRK2
(Vaccinia Related Kinase 2 (VRK2))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- YKNPDQVYLA DYGLSYRYCP NGNHKQYQEN PRKGHNGTIE FTSLDAHKGV
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- VRK2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- VRK2 (Vaccinia Related Kinase 2 (VRK2))
-
Sujet
-
This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity.
Protein Size: 454 -
ID gène
- 7444
-
NCBI Accession
- NM_001130480, NP_001123952
Antigène
-
Vous êtes ici:
